Recent articles
Here's Why Aurora Cannabis Doesn't Deserve a Top-Shelf Valuation
A bet on this Canadian marijuana company is a bet on the political future of the country south of its home market.
3 Top Biotech Stocks to Buy in September
These three biotech stocks could be great buys this month.
Does Acadia Pharmaceuticals Have More Room to Run?
Acadia's stock has taken flight this year.
Why Amicus Therapeutics Tanked in August
Investor concerns over the competitive outlook for the company's Pompe disease therapy candidate weighed on its stock price.
Why Amgen Stock Perked Up Last Month
Amgen's best-selling medicine is safe from biosimilar competition for now.
Is Dynavax Technologies a Buy?
Dynavax's stock surged higher in August. Can this small-cap biotech keep churning higher?
Why Acadia Pharmaceuticals Stock Skyrocketed Today
Acadia's flagship drug notched a key late-stage win today.
Amarin: Keep Your Dry Powder Ready
Biotech stocks tend to react badly to advisory committee meetings.
Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics
The biotech rivals each aim to dominate the treatment market for non-alcoholic steatohepatitis (NASH).
3 Top Biotech Stocks to Buy Right Now
Patent cliffs and pipeline risks are among the reasons these biologic drug specialists are attractively priced today.
Why Retrophin, Inc. Is Tanking Today
Retrophin's PKAN drug candidate missed the mark in a late-stage trial.
3 Top Healthcare Stocks to Buy Right Now
These three health care stocks deserve your undivided attention right now.
3 Top Diabetes Stocks to Watch in August
These three diabetes-oriented companies should be on your radar right now.
Why Sarepta Therapeutics Stock Is Crashing Today
A surprise rejection is weighing on Sarepta's shares today.
Why Novavax Stock Is Soaring Today
Novavax's RSV vaccine may not be dead after all.
Why Amarin Stock Is Tanking Today
The FDA will hold an advisory committee meeting after all.
Why Sarepta Therapeutics Stock Tanked on Thursday
Its high-profile DMD gene-therapy candidate hit an unexpected stumbling block.
Why Catalyst Pharmaceuticals Stock Broke Down Today
Catalyst's shares took a sizable hit this morning.
Avedro and Glaukos Join Forces
Glaukos makes a bid for Avedro in an all-stock transaction.
3 Top Cannabis Stocks to Watch in August
Canopy Growth, Charlotte's Web Holdings, and HEXO Corp. are worth checking out this month. Here's why.